Medicinal Cannabis Matters: Friday Roundup - 4 September 2026

What’s Next for the Global Cannabis Industry?

As we move towards the final part of 2026, Business of Cannabis has revisited its predictions for the year to see what has changed and what the industry could expect next.

The mid-year update highlights a cannabis industry that continues to develop at very different speeds across different markets. Regulatory reform remains a major theme, with countries including Germany, Australia and Thailand continuing to consider how their medical cannabis frameworks should evolve.

The global market is being shaped by changing supply and pricing dynamics. Increased production and international trade are putting pressure on prices in some markets, while businesses are increasingly having to adapt to more mature and closely regulated markets.

For patients, these international developments may seem a long way from day-to-day treatment. However, changes to regulation, supply chains and clinical frameworks can ultimately influence which medicines are available and how easily patients can access them.

As the global medicinal cannabis sector matures, the focus is increasingly shifting from simply creating access to building sustainable, regulated healthcare systems around it.

Understanding the Law with Medical Cannabis and Driving

Driving is an important consideration for many patients using medicinal cannabis, but the law can be difficult to navigate.

A new article from Cannabis Health News looks at the current position in the UK, including the distinction between having THC in your system and actually being impaired.

Under UK law, it is an offence to drive while your ability is impaired. However, patients who have been legally prescribed medicinal cannabis and are taking it in accordance with their prescription may have a statutory medical defence to the specified-limit offence. This does not provide protection if someone is actually impaired and unfit to drive.

Patients should always be aware of how their medication affects them and should not drive if they feel impaired.

What Does Being Eligible for Medical Cannabis Actually Mean?

With more people becoming aware that medicinal cannabis is legally available in the UK, one question comes up regularly: Who can actually access it?

A new article from Leafie explores what eligibility means in practice and why simply having a particular diagnosis does not automatically mean someone will be prescribed medicinal cannabis.

Medicinal cannabis can be prescribed privately in the UK by specialist doctors for patients who meet the appropriate clinical criteria. In practice, clinicians will consider the patient's condition, their symptoms, previous treatments and whether medicinal cannabis is an appropriate option based on their individual circumstances.

Eligibility is therefore not simply a checklist of conditions. Two people with the same diagnosis may have very different medical histories, symptoms and responses to previous treatments, meaning a clinician needs to consider each patient individually.

This is an important part of responsible prescribing. A legal prescription for medicinal cannabis should follow a proper clinical assessment, with treatment decisions based on the individual patient rather than a diagnosis alone.

As the sector continues to grow, education remains an important part of making sure patients understand their treatment and their rights.

At Medicann, we believe patients should have access to safe, clinically supervised treatment, alongside clear and evidence-led information.

If you're considering whether medicinal cannabis may be suitable for your condition, you can check your eligibility online in just two minutes.

Disclaimer: This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.